JERECZEK, BARBARA ALICJA
 Distribuzione geografica
Continente #
EU - Europa 27.046
NA - Nord America 9.612
AS - Asia 6.251
SA - Sud America 193
OC - Oceania 114
AF - Africa 111
Continente sconosciuto - Info sul continente non disponibili 12
Totale 43.339
Nazione #
DE - Germania 14.993
US - Stati Uniti d'America 9.374
GB - Regno Unito 4.169
IT - Italia 2.816
CN - Cina 2.595
SE - Svezia 1.450
SG - Singapore 1.232
RU - Federazione Russa 738
IE - Irlanda 703
IN - India 634
FR - Francia 580
TR - Turchia 460
KR - Corea 410
UA - Ucraina 340
FI - Finlandia 298
NL - Olanda 234
HK - Hong Kong 215
CA - Canada 200
ID - Indonesia 196
EU - Europa 183
VN - Vietnam 173
DK - Danimarca 169
JP - Giappone 120
ES - Italia 115
AU - Australia 101
PL - Polonia 90
PH - Filippine 74
BE - Belgio 73
BR - Brasile 63
CH - Svizzera 63
CO - Colombia 59
MA - Marocco 59
GR - Grecia 37
AT - Austria 34
PT - Portogallo 34
CL - Cile 28
TW - Taiwan 28
MX - Messico 23
IR - Iran 22
AR - Argentina 21
RO - Romania 21
NO - Norvegia 18
CZ - Repubblica Ceca 17
TH - Thailandia 16
MY - Malesia 15
EG - Egitto 13
IL - Israele 13
NG - Nigeria 13
NZ - Nuova Zelanda 13
CR - Costa Rica 10
EC - Ecuador 10
PE - Perù 10
PK - Pakistan 10
TN - Tunisia 10
HU - Ungheria 9
ZA - Sudafrica 8
RS - Serbia 7
AE - Emirati Arabi Uniti 6
IS - Islanda 6
SC - Seychelles 6
SK - Slovacchia (Repubblica Slovacca) 6
BD - Bangladesh 5
BG - Bulgaria 4
HR - Croazia 4
SI - Slovenia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EE - Estonia 3
JO - Giordania 3
LK - Sri Lanka 3
LU - Lussemburgo 3
SA - Arabia Saudita 3
SY - Repubblica araba siriana 3
AD - Andorra 2
AM - Armenia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
MN - Mongolia 2
UZ - Uzbekistan 2
VE - Venezuela 2
AL - Albania 1
BT - Bhutan 1
BZ - Belize 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
IM - Isola di Man 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
PR - Porto Rico 1
TJ - Tagikistan 1
Totale 43.513
Città #
Frankfurt am Main 14.077
Southend 3.797
Chandler 1.323
Milan 1.003
Princeton 815
Singapore 807
Seattle 727
Dublin 686
Wilmington 607
Ashburn 446
Beijing 425
Fairfield 411
Bengaluru 299
Nanjing 267
Des Moines 254
Redmond 242
Dearborn 238
Houston 232
Woodbridge 215
Cambridge 211
Mountain View 198
Jacksonville 196
Ann Arbor 166
Phoenix 154
Toronto 153
Jinan 152
Sakarya 148
Redwood City 134
Shanghai 128
Hong Kong 123
Boardman 121
Jakarta 121
Rome 118
New York 116
Santa Clara 112
Shenyang 108
Berlin 105
Hyderabad 98
Grafing 90
Helsinki 89
Dong Ket 77
Nanchang 77
Tianjin 66
Andover 65
Changsha 62
Eitensheim 59
Guangzhou 59
Hebei 58
Brussels 57
Medford 57
Seoul 55
Bogotá 54
San Diego 54
Hangzhou 53
Central District 46
Warsaw 46
Munich 45
Turin 45
Nuremberg 42
Serra 41
London 40
Florence 39
Haikou 39
Los Angeles 39
Jiaxing 38
Cinisello Balsamo 37
Somerville 34
Tokyo 34
Athens 33
Roxbury 32
Chengdu 31
Pavia 31
Casablanca 30
Istanbul 29
Mumbai 29
Silver Spring 29
Boston 28
Bühl 28
Paris 28
Barcelona 27
Verona 27
Chicago 26
Kunming 26
Madrid 25
Sydney 25
Zhengzhou 25
Fremont 24
Melbourne 24
Ningbo 23
Rho 23
São Paulo 23
Upper Marlboro 23
Norwalk 22
Taizhou 22
Washington 22
Kent 20
Vienna 20
Duncan 19
Amsterdam 18
Bologna 18
Totale 31.940
Nome #
Salvage stereotactic body radiotherapy for local prostate cancer recurrence after radiotherapy: a retrospective multicentre study of the GETUG 864
A novel nomogram to identify candidates for active surveillance among patients with ISUP Grade Group 1 or ISUP Grade Group 2 prostate cancer, according to multiparametric magnetic resonance imaging findings 321
Evaluation of target coverage and margins adequacy during CyberKnife Lung Optimized Treatment 272
Low PI-RADS assessment category excludes extraprostatic extension (≥pT3a) of prostate cancer : a histology-validated study including 301 operated patients 268
Treatment of muscle-invasive bladder cancer in patients without comorbidities and fit for surgery: Trimodality therapy vs radical cystectomy. Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 268
Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): Potential of imaging and biology (AIRC IG-22159) 254
Association of quantitative mri-based radiomic features with prognostic factors and recurrence rate in oropharyngeal squamous cell carcinoma 234
No increase in toxicity of pelvic irradiation when intensity modulation is employed: clinical and dosimetric data of 208 patients treated with post-prostatectomy radiotherapy 218
Cisplatin, etoposide and continuous infusion bleomycin in patients with testicular germ cell tumors: efficacy and toxicity data from a retrospective study 216
Linee guida carcinoma della prostata : AIRO, 2016 216
[11C]Choline PET/CT impacts treatment decision making in patients with prostate cancer referred for radiotherapy 208
Repeated MRIs during Active Surveillance: natural history of prostatic lesions and upgrading rates 207
Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT) 204
STRA-MI-VT (STereotactic RadioAblation by Multimodal Imaging for Ventricular Tachycardia) : rationale and design of an Italian experimental prospective study 204
Tossicità con radioterapia e brachiterapia 201
MR imaging for selection of patients for partial breast irradiation : a systematic review and meta-analysis 194
Machine Learning-Based Models for Prediction of Toxicity Outcomes in Radiotherapy 194
Adjuvant radiotherapy treatment for soft tissue sarcoma of extremities and trunk. A retrospective mono-institutional analysis 194
Salvage image-guided intensity modulated or stereotactic body reirradiation of local recurrence of prostate cancer 191
M. D. Anderson symptom inventory head neck (MDASI-HN) questionnaire: Italian language psychometric validation in head and neck cancer patients treated with radiotherapy ± systemic therapy – A study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 188
Value of perfusion CT parameters, microvessl density and VEGF expression in differentiation of benign and malignant prostate tumours 180
Adjuvant and salvage radiation therapy after prostatectomy : investigating beliefs and practices of radiation oncologists 180
Perfusion CT is a valuable diagnostic method for prostate cancer: a prospective study of 94 patients 177
Head and neck cancer radiotherapy amid COVID‐19 pandemic : Report from Milan, Italy 173
Bladder preservation in non-metastatic muscle-invasive bladder cancer (MIBC): a single-institution experience 172
OLIGO-AIRO: a national survey on the role of radiation oncologist in the management of OLIGO-metastatic patients on the behalf of AIRO 170
Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P) : inter-observer agreement between readers of different expertise levels 165
Voxel-based analysis unveils regional dose differences associated with radiation-induced morbidity in head and neck cancer patients 164
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 164
Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors 163
Phase II prospective trial “Give Me Five” short-term high precision radiotherapy for early prostate cancer with simultaneous boost to the dominant intraprostatic lesion : the impact of toxicity on quality of life (AIRC IG-13218) 163
Robot-assisted radical prostatectomy : multiparametric MR imaging-directed intraoperative frozen-section analysis to reduce the rate of positive surgical margins 163
Low Dose Rate Brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy : Practice and outcome analysis in a series of 2237 patients from 11 Institutions 162
Correction: Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up (Prostate Cancer and Prostatic Diseases, (2020), 23, 1, (94-101), 10.1038/s41391-019-0160-3) 159
"Give me five" ultra-hypofractionated radiotherapy for localized prostate cancer: non-invasive ablative approach 158
Ductal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series 158
The QUBIC instrument for CMB polarization measurements 158
Acute toxicity of image-guided hypofractionated radiotherapy for prostate cancer: nonrandomized comparison with conventional fractionation 156
COVID-19 outbreak and cancer radiotherapy disruption in Italy : Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 155
Whole-body magnetic resonance imaging: Technique, guidelines and key applications 155
CyberKnife®; Imaging-dose evaluation during IGRT-SRSand IGRT-SBRT treatments 154
Beyond D'Amico risk classes for predicting recurrence after external beam radiotherapy for prostate cancer: the Candiolo classifier 152
Recent advances in radiation oncology 151
The PROCAINA (Prostate Cancer Indication Attitudes) Project (Part I): A survey among Italian radiation oncologists on post-operative radiotherapy in prostate cancer 150
Cytoreductive prostate radiotherapy in oligometastatic prostate cancer: A single centre analysis of toxicity and clinical outcome 149
Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: Is It Oncologically Safe? A Retrospective Matched-Cohort Analysis 148
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 147
Acute radiation dermatitis in breast cancer : topical therapy with vitamin E acetate in lipophilic gel 146
Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up 146
Therapeutic Sequences in the Treatment of High-Risk Prostate Cancer: Paving the Way Towards Multimodal Tailored Approaches 146
Chemioterapia versus naprzemienna chemio-radioterapia u chorych z ograniczona postacia drobnokomórkowego raka pluca 145
MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218) 141
PROACTA: a survey on the actual attitude of the Italian radiation oncologists in the management and prescription of hormonal therapy in prostate cancer patients 141
Dose escalation for prostate cancer using the three-dimensional conformal dynamic arc technique : analysis of 542 consecutive patients 140
Dosimetric Impact of Inter-Fraction Anatomical Changes in Carbon Ion Boost Treatment for High-Risk Prostate Cancer (AIRC IG 14300) 140
Mixup (Sample Pairing) Can Improve the Performance of Deep Segmentation Networks 140
A global Unified Dosimetry Index (gUDI) to evaluate simultaneous integrated boost radiotherapy plans in prostate cancer 139
Intraoperative radiotherapy during radical prostatectomy for intermediate-risk to locally advanced prostate cancer: treatment technique and evaluation of perioperative and functional outcome vs standard radical prostatectomy, in a matched-pair analysis 138
Volumetric modulated arc therapy with rapidarc (RA-IMRT) for gunaecological malignancies 138
Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300 138
Effects of sex and age on fat fraction, diffusion-weighted image signal intensity and apparent diffusion coefficient in the bone marrow of asymptomatic individuals: A cross-sectional whole-body mri study 137
Urinary bladder preservation for muscle-invasive bladder cancer: a survey among radiation oncologists of Lombardy, Italy 136
Clinical risk analysis of the patient’s path in an Advanced Radiotherapy Center (A.R.C.) through F.M.E.A. method 136
Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer : a review 135
20 Gy in five fractions versus 8 Gy in one fraction in palliative radiotherapy of bone metastases : a multicenter randomized study 135
A qualitative investigation on patient empowerment in prostate cancer 134
Stereotactic body radiotherapy for castration-sensitive prostate cancer bone oligometastases 134
Management of patients with cardiac implantable electronic devices (CIED) undergoing radiotherapy : a consensus document from Associazione Italiana Aritmologia e Cardiostimolazione (AIAC), Associazione Italiana Radioterapia Oncologica (AIRO), Associazione Italiana Fisica Medica (AIFM) 134
Mammella. Radioterapia del carcinoma della mammella 133
Adaptive mathematical model of tumor response to radiotherapy based on CBCT data 133
Domande dei lettori 132
Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence : A Multi-institutional Analysis 132
Comparing TomoHelical and TomoDirect in postmastectomy hypofractionated radiotherapy after immediate breast reconstruction 132
Radiotherapy in prostate cancer patients with pelvic lymphocele after surgery: clinical and dosimetric data of 30 patients 131
Influence of different urinary bladder filling levels and controlling regions of interest selection on deformable image registration algorithms 131
Late toxicity of image-guided hypofractionated radiotherapy for prostate : non-randomized comparison with conventional fractionation 130
Adjuvant radiotherapy in node positive prostate cancer patients: a debate still on. when, for whom? 130
Short-term high precision radiotherapy for early prostate cancer with concomitant boost to the dominant lesion : ad interim analysis and preliminary results of Phase II trial AIRC-IG-13218 129
Oligorecurrent Prostate Cancer and Stereotactic Body Radiotherapy: Where Are We Now? A Systematic Review and Meta-analysis of Prospective Studies 129
High-performance prediction models for prostate cancer radiomics 128
Model-supported radiotherapy personalization : in silico test of hyper- and hypo-fractionation effects 128
Predicting Pathological Features at Radical Prostatectomy in Patients with Prostate Cancer Eligible for Active Surveillance by Multiparametric Magnetic Resonance Imaging 127
Repeat computer tomography imaging to detect dosimetric changes for head and neck IMRT plans 126
Intra- and inter-observer variability in breast tumour bed contouring and the controversial role of surgical clips 126
VERO (R) radiotherapy for low burden cancer: 789 patients with 957 lesions 126
Clinical evaluation and disease management of PI-RADS 3 lesions. Analysis from a single tertiary high-volume center 126
Reporting combined outcomes with Trifecta and survival, continence, and potency (SCP) classification in 337 patients with prostate cancer treated with image-guided hypofractionated radiotherapy 125
Use of artificial neural networks to predict acute rectal toxicity after external beam radiotherapy for prostate carcinoma 124
Correlation between EGFr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinoma 124
High-dose-rate Brachytherapy as Adjuvant Local rEirradiation for Salvage Treatment of Recurrent breAst cancer (BALESTRA): a retrospective mono-institutional study 124
Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients 124
COVID-19 and radiotherapy: impact on work and personal life of Lombardy residents during first lockdown, survey endorsed by AIRO Young 124
Image-guided radiotherapy for prostate cancer using 3 different techniques : localization data of 186 patients 123
COMBINED SURGERY AND POST-OPERATIVE RADIOTHERAPY OR CHEMORADIOTHERAPY FOR LOCALLY ADVANCED TONGUE CANCER 122
Long-Term Results and Reconstruction Failure in Patients Receiving Postmastectomy Radiation Therapy with a Temporary Expander or Permanent Implant in Place 122
Three-times daily radiotherapy after chemotherapy in stage III non-small cell lung cancer. Single-institution prospective study 121
Correlation between acute and late toxicity in 973 prostate cancer patients treated with three-dimensional conformal external beam radiotherapy 120
Intraprostatic fiducial markers: A potential application for ultrasound-guided radiotherapy in prostate cancer 120
The role of [18F]FDG-PET/CT in staging and treatment planning for volumetric modulated Rapidarc radiotherapy in cervical cancer : experience of the European Institute of Oncology, Milan, Italy 119
Machine Learning for Head and Neck Cancer: A Safe Bet?—A Clinically Oriented Systematic Review for the Radiation Oncologist 119
Totale 16.421
Categoria #
all - tutte 117.043
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.043


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.941 0 0 106 388 186 314 456 195 531 454 215 96
2020/20213.660 286 217 178 194 293 401 208 193 562 189 602 337
2021/20224.110 167 139 135 163 258 301 266 269 379 447 377 1.209
2022/20236.043 741 571 511 639 511 1.088 223 401 647 119 400 192
2023/202414.288 193 308 335 255 956 523 2.251 1.992 986 1.920 2.269 2.300
2024/20255.998 2.158 2.230 1.610 0 0 0 0 0 0 0 0 0
Totale 45.867